Injectable PrEP

Want to contribute to the next phase of PrEP Research?

The Injectable PrEP study is testing a new form of PrEP. Participants will receive an injection every 8 weeks to determine if injectable Cabotegravir is as effective as daily oral Truvada for PrEP at preventing HIV infection. We are looking for 18+ year old, HIV uninfected transwomen and men who have sex with men. Participants will be compensated for their time.

For more information please call 617.927.6450 or email

Please click here to take an online screener to see if you may be eligible.

Translate »